peptide-yy has been researched along with Hodgkin-Disease* in 1 studies
1 other study(ies) available for peptide-yy and Hodgkin-Disease
Article | Year |
---|---|
[Pro34]peptide YY is a Y1-selective agonist at peptide YY/neuropeptide Y receptors.
We have investigated binding and functional effects of a new peptide YY analogue, [Pro34]peptide YY, at Y1 and Y2-like subtypes of receptors for peptide YY and neuropeptide Y. In binding studies [Pro34]peptide YY had a similarly high affinity as peptide YY to human Y1-like receptors in SK-N-MC cells, a human neuroblastoma cell line of presumed neurogenic origin, and HEL cells, a human cell line derived from a patient with Hodgkin's disease. In functional studies [Pro34]peptide YY stimulated Ca2+ elevations in both Y1-like receptor cell lines with similar potency and efficacy as peptide YY. In contrast to peptide YY [Pro34]peptide YY was 1000-fold less potent in binding to Y2-like receptors in porcine splenic membranes and lacked agonistic effects in another Y2-like receptor-mediated model system, i.e. inhibition of [3H]serotonin release from rat cerebral cortical slices. Thus, [Pro34]peptide YY is a highly Y1-selective full agonist of peptide YY/neuropeptide Y receptors. [Pro34]peptide YY could be useful for studying the importance of Y receptor subtypes in mediating peptide YY physiological actions. Topics: Amino Acid Sequence; Animals; Binding, Competitive; Brain Neoplasms; Calcium; Cerebral Cortex; Hodgkin Disease; Humans; In Vitro Techniques; Molecular Sequence Data; Neuroblastoma; Peptide YY; Peptides; Radioligand Assay; Rats; Receptors, Gastrointestinal Hormone; Serotonin; Swine; Tumor Cells, Cultured | 1994 |